Groundbreaking research on Idiopathic Systemic Capillary Leak Syndrome: FX06 is Pioneering New Frontiers in Clarkson Disease Treatment
Our COVend consortium member F4 Pharma’s cooperation partners presented groundbreaking research on Idiopathic Systemic Capillary Leak Syndrome (ISCLS), also known as Clarkson disease, first at the 124° Congresso Nazionale of the Societa Italiana di Medicina Interna (SIMI) in October 2023. Now their paper is officially published in Biomedicine & Pharmacotherapy.
COVend presented at ISPOR Europe 2023
On the 13th of November, the consortium member of our partner institution UMCG, Clazinus Veijer, presented his poster “Lessons learned from model-based economic evaluations of COVID-19 treatments under pandemic circumstances: results from a systematic review ” at ISPOR Europe 2023. The poster highlighted results from a systematic review of various methodological characteristics of model-based economic evaluations of COVID-19 treatments.
COVend presented at the joint conference of the Société Française d’Immunologie and Deutsche Gesellschaft für Immunologie in Strasbourg
Exciting research from COVend presented at the joint conference of the Société Française d’Immunologie & Deutsche Gesellschaft für Immunologie in Strasbourg!
COVend Partners at University College Dublin Uncover Unique Cytokine Response in COVID-19
COVend Partners at University College Dublin Uncover Unique Cytokine Response in COVID-19 In the ongoing fight against COVID-19, COVend is dedicated to pushing the boundaries of scientific knowledge. Together with […]
COVend and UN SDGs: Contributing to Shaping a Healthier World
In 2015, the United Nations adopted the 17 Sustainable Development Goals (SDGs) as a global blueprint for addressing pressing challenges. These goals guide our efforts to combat poverty, inequality, climate change, and environmental concerns. Among them, two pivotal goals stand out – SDG 3: Good Health and Well-being, and SDG 9: Industry, Innovation and Infrastructure.
New Findings on FX06 and its Therapeutic Potential from the COVend Research Teams
What do an economist, a biochemist, and a clinician have in common? As it turns out, they can all benefit from the latest findings on FX06. The researchers from University College Dublin and the University Medical Center Groningen, the esteemed COVend consortium partners, have revealed new information on FX06 and its potential role in addressing hyperinflammation and capillary leak.
COVend publication: “Reperfusion Injury: Mechanisms, Interventions, and Clinical Perspectives”
COVend publication: “Reperfusion Injury: Mechanisms, Interventions, and Clinical Perspectives” We are thrilled to announce the publication of “Reperfusion Injury: Mechanisms, Interventions, and Clinical Perspectives” by our esteemed partners Jan Kloka, […]
Highway to Health – The future of Healthcare in Europe
Highway to Health – the future of Healthcare in Europe COVend & ENVISION Cluster and Policy Event On 4 July 2023 the two project consortia of COVend and ENVISION, held […]
COVend represented at Euroanaesthesia 2023 Congress
COVend represented at Euroanaesthesia Congress 2023 The COVend partners European Society of Anaesthesiology and Intensive Care (ESAIC), held a successful Euroanaesthesia 2023 (EA23) Congress from 03 June 2023 – 05 […]
HIGHWAY TO HEALTH – EVENT REGISTRATION OPEN
HIGHWAY TO HEALTH – EVENT REGISTRATION OPEN Register for our joint COVend & ENVISION Cluster and Policy Event “Highway to Health — Visions in European Healthcare” at the Representation of the State […]
